ANI Pharmaceuticals ANIP Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's change in inventories?
- ANI Pharmaceuticals (ANIP) reported change in inventories of $437K in Q1 2026.
- How has ANI Pharmaceuticals's change in inventories changed year-over-year?
- ANI Pharmaceuticals's change in inventories decreased by 30.1% year-over-year, from $625K to $437K.
- What is the long-term trend for ANI Pharmaceuticals's change in inventories?
- Over 2 years (2022 to 2024), ANI Pharmaceuticals's change in inventories has grown at a -5.1% compound annual growth rate (CAGR), from $23.63M to $21.29M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.